---
figid: PMC7884707__41392_2020_430_Fig3_HTML
figtitle: Hedgehog (Hh) signaling pathway-mediated therapy resistance in CSCs
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- NA
pmcid: PMC7884707
filename: 41392_2020_430_Fig3_HTML.jpg
figlink: pmc/articles/PMC7884707/figure/Fig3/
number: F3
caption: Hedgehog (Hh) signaling pathway-mediated therapy resistance in CSCs. Binding
  of the Hh ligand to its receptor Patched (PTCH) enables Smoothened (SMO)-mediated
  translocation of glioma-associated protein 1/2(Gli1/2) to the cell nucleus to drive
  the transcription of Shh target genes. During activation of the Hh pathway, some
  proteins (IL-6, MFG-E8), microRNA (miR-200b, let-7c) and the long noncoding RNA
  LncRNA-CSC1 are involved in the Hedgehog pathway to regulate EGFR-TKI resistance,
  Imatinib resistance, Cisplatin resistance, and Erlotinib resistance
papertitle: 'Targeting cancer stem cells for reversing therapy resistance: mechanism,
  signaling, and prospective agents.'
reftext: He-Ming Zhou, et al. Signal Transduct Target Ther. 2021;6:62.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.930479
figid_alias: PMC7884707__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7884707__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7884707__41392_2020_430_Fig3_HTML.html
  '@type': Dataset
  description: Hedgehog (Hh) signaling pathway-mediated therapy resistance in CSCs.
    Binding of the Hh ligand to its receptor Patched (PTCH) enables Smoothened (SMO)-mediated
    translocation of glioma-associated protein 1/2(Gli1/2) to the cell nucleus to
    drive the transcription of Shh target genes. During activation of the Hh pathway,
    some proteins (IL-6, MFG-E8), microRNA (miR-200b, let-7c) and the long noncoding
    RNA LncRNA-CSC1 are involved in the Hedgehog pathway to regulate EGFR-TKI resistance,
    Imatinib resistance, Cisplatin resistance, and Erlotinib resistance
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Caf
  - Ccn3
  - Plxna1
  - Igf1
  - Mfge8
  - Shh
  - Il6
  - Ptch1
  - Sufu
  - Gli1
  - Gli2
  - Gli3
  - Kif3a
  - Mir200b
  - KAT2B
  - INHBA
  - CCN3
  - PLXNA1
  - RPL10
  - IGF1
  - MFGE8
  - SHH
  - IL6
  - PTCH1
  - SUFU
  - GLI1
  - GLI2
  - GLI3
  - KIF3A
  - MIR200B
  - MIRLET7C
  - CAF
  - TAM
  - PTCH
  - Imatinib
  - Cisplatin
  - Erlotinib
---
